BMJ  2003;327 (11 October), doi:10.1136/bmj.327.7419.0-d

Preventive drug treatment decisions are individualised

Lay people expect greater benefits than clinicians when considering drug treatments to prevent heart attacks, and may decline treatment even if well informed. Lewis and colleagues (p 841) interviewed general practitioners, practice nurses, and lay people and found that all groups experienced difficulty understanding numerical risk-benefit scenarios. Lay people uniquely balanced benefits against adverse effects, cost, and quality of life, resulting in a wide range of unpredictable treatment thresholds. Some said that they preferred lifestyle change to drugs, while a few lay people wanted only treatment with 100% effectiveness and safety. Johnstone (p 844) offers a patient commentary on living with a chronic illness and making decisions about drug taking.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Factors involved in deciding to start preventive treatment: qualitative study of clinicians' and lay people's attitudes
David K Lewis, Jude Robinson, and Ewan Wilkinson
BMJ 2003 327: 841. [Abstract] [Full Text] [PDF]

A small study, but the results ring true
Robert Johnstone
BMJ 2003 327: 844-845. [Full Text] [PDF]




Access all current jobs at BMJ Group
Whats new online at Student 

BMJ
Listen to the latest 

BMJ Interview